PATIENTS' AND HAEMATOLOGISTS' PREFERENCES ON IMMUNE THROMBOCYTOPENIA (ITP) TREATMENT ALTERNATIVES: A CONJOINT ANALYSIS

被引：0
|
作者：
Alvarez, M. T. [1 ]
Pascual-Izquierdo, C. [2 ]
Sanchez-Gonzalez, B. [3 ]
Di Nicolantonio, R. [4 ]
Gostkorzewicz, J. [4 ]
Morros, M. [5 ]
Artes, M. [5 ]
机构：
[1] La Paz Univ Hosp IdiPaz, Madrid, Spain
[2] Hosp Gen Univ Gregorio Maranon, Madrid, Spain
[3] Hosp Mar Parc Salut, Barcelona, Spain
[4] Novartis Spain, Barcelona, Spain
[5] Adelphi Spain, Barcelona, Spain
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY42
引用
收藏
页码：S909 / S909
页数：1
相关论文
共 50 条
  • [31] Protocol for the study and treatment of primary immune thrombocytopenia: ITP-2018
    Monteagudo, Emilio
    Astigarraga, Itziar
    Cervera, Aurea
    Angeles Dasi, Maria
    Sastre, Ana
    Berrueco, Ruben
    Luis Dapena, Jose
    ANALES DE PEDIATRIA, 2019, 91 (02):
  • [32] CHARACTERIZATION AND TREATMENT OF IMMUNE THROMBOCYTOPENIA (ITP) IN EUROPE: A QUALITATIVE OBSERVATIONAL STUDY
    Pogna, E.
    Middleton, S.
    Nazir, J.
    Ralph, L.
    Wilson, K.
    Jurczak, W.
    VALUE IN HEALTH, 2021, 24 : S203 - S203
  • [33] GAUCHER DISEASE WITH IMMUNE THROMBOCYTOPENIA (ITP): A CASE REPORT AND TREATMENT WITH ELTROMBOPAG
    L, M. Borin
    Verga, L.
    Farina, F.
    Aroldi, A.
    Pioltelli, P. E.
    HAEMATOLOGICA, 2016, 101 : 830 - 830
  • [34] Influence of the treatment of immune thrombocytopenia (ITP) with Eltrombopag on the fatigue symptoms of ITP patients - Results of the third interim analysis of the German non-interventional study RISA
    Meyer, O.
    Stauch, M.
    Kaempfe, D.
    Schlag, R.
    Reiser, M.
    Stauch, T.
    von der Heyde, E.
    Josting, A.
    Plath, M.
    Ballerstaedt, N.
    Stark-Lorenzen, P.
    Scheibenbogen, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 179 - 179
  • [35] Conjoint analysis a technique to develop a questionnaire of treatment preferences in patients with lung cancer
    Perulero, N.
    Cardenal, F.
    Garcia, R.
    Juan, O.
    S, Vazquez
    Barneto, I
    Varela, C.
    VALUE IN HEALTH, 2007, 10 (06) : A344 - A345
  • [36] Analysis of Mortality Rates During Romiplostim Clinical Studies of Patients (Pts) with Immune Thrombocytopenia (ITP)
    Gernsheimer, Terry
    Kuter, David J.
    Cines, Douglas B.
    Stasi, Roberto
    Rummel, Mathias J.
    Godeau, Bertrand
    Guo, Matthew
    Franklin, Janet
    BLOOD, 2010, 116 (21) : 1518 - 1519
  • [37] Pooled Analysis of Safety and Efficacy of Romiplostim in Splenectomized and Nonsplenectomized Patients (pts) with Immune Thrombocytopenia (ITP)
    Rodeghiero, Francesco
    Provan, Andrew
    Steurer, Michael
    Godeau, Bertrand
    Carpenter, Nancy
    Kreuzbauer, Georg
    BLOOD, 2014, 124 (21)
  • [38] SAFETY ANALYSIS OF LONG-TERM ROMIPLOSTIM USE IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (ITP)
    Rodeghiero, F.
    Provan, D.
    Cines, D.
    Stasi, R.
    Tarantino, M.
    Nie, K.
    Jun, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 73 - 74
  • [39] Patients' preferences for treatment outcomes of add-on antiepileptic drugs: A conjoint analysis
    Manjunath, Ranjani
    Yang, Jui-Chen
    Ettinger, Alan B.
    EPILEPSY & BEHAVIOR, 2012, 24 (04) : 474 - 479
  • [40] Assessing Drug Treatment Preferences of Patients with Crohn’s DiseaseA Conjoint Analysis
    Gary R. Lichtenstein
    Heidi C. Waters
    Jenna Kelly
    Susan S. McDonald
    Elaine L. Zanutto
    David Hendricks
    Mirza I. Rahman
    The Patient: Patient-Centered Outcomes Research, 2010, 3 : 113 - 123
12345